corona remedies limited IPO

The Corona Remedies Limited IPO subscription status shows how many times the issue has been subscribed across different investor categories such as QIB, NII (HNI), and Retail. It reflects the demand for the IPO during the subscription period.

You can check live Corona Remedies Limited IPO subscription data on this page, which is updated based on official exchange data released during the IPO subscription period.

The Corona Remedies Limited IPO subscription is divided into the following categories: Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII / HNI), and Retail Individual Investors (RII). Each category has a separate quota and subscription data.

QIB subscription in Corona Remedies Limited IPO indicates the demand from institutional investors such as mutual funds, banks, and insurance companies.

NII (also known as HNI) subscription in Corona Remedies Limited IPO represents bids from high-net-worth investors who apply for shares above the retail limit.

Retail subscription in Corona Remedies Limited IPO shows demand from individual investors who apply within the retail investment limit specified in the IPO details.

Corona Remedies Limited IPO subscription data is updated multiple times during market hours based on information published by stock exchanges.

No, higher Corona Remedies Limited IPO subscription does not guarantee allotment. In case of oversubscription, allotment is done through a lottery system as per SEBI guidelines.

Yes, the subscription data shown for Corona Remedies Limited IPO is based on official data released by stock exchanges, but it may change during the day.

IPO subscription indicates demand, but the actual listing performance depends on market conditions, company fundamentals, and investor sentiment at the time of listing.